HSCS logo

HEARTSCIENCES INC

HSCSNASDAQ
πŸ† #4750 by market capEarnings Dec 21US Equity
β€”β€”
Quote unavailable
πŸ””
Track HSCS
Get earnings, price moves & breaking news on Telegram
Track
24hβ€”
7dβ€”
14dβ€”
30dβ€”
ytdβ€”
1yβ€”
🏦Market Cap
$10M
Small Cap
πŸ“ˆRevenue Growth (YoY)
-0.7%
Declining
πŸ“ŠGross Margin
-2908.8%
Thin
πŸ’΅FCF Margin
-151268.8%
Thin
βš–οΈP/S Ratio
2270.4x
Expensive
Otter Score
β€”
Insufficient data
No chart data available for HSCS.

Trading Snapshot

Day Range
β€”
52-Week Range
$1.63 – $5.25
Volume (shares)
β€”
Avg Volume (shares)
β€”
Shares Outstanding
5.7M
Next Earnings
2026-12-21

Fundamentals Snapshot

Annual Revenue
$4,319
Last Q Revenue
$2,100
P/E Ratio
-0.6
P/S Ratio
2270.4x
EPS (TTM)
$-2.80
Dividend Yield
0.00%
Dilution (1yr)
+39.7%
HSCS logo

HEARTSCIENCES INC

HSCS
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$4Kβ–Ό βˆ’0.7% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
-2982.1%β–² +3.4% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$8Mβ–² +0.7% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
βˆ’$7Mβ–² +0.4% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
3.7Mβ–² +39.7% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$26Mβ–Ό βˆ’$1.6B YoY
StockOtter Β· stockotter.space

About HEARTSCIENCES INC

HeartSciences Inc. is a medical technology company dedicated to augmenting the clinical utility of electrocardiograms (ECGs) by integrating artificial intelligence (AI). The firm develops AI-enhanced ECG (AI-ECG) solutions, including an algorithm specifically designed to detect impaired cardiac relaxation or other forms of cardiac dysfunction, whether caused by heart disease or the natural aging process. Among its offerings is the MyoVista wavECG device, a 12-lead resting ECG that provides comprehensive diagnostic information concerning cardiac function alongside conventional ECG data in a single examination. Furthermore, the company offers MyoVista Insights, a cloud-based platform capable of hosting its AI-ECG algorithms across various ECG hardware systems. Established in 2007, HeartSciences Inc. operates from its headquarters in Southlake, Texas. The company was formerly named Heart Test Laboratories, Inc. until its rebranding to HeartSciences Inc. in October 2024.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Insufficient data
β€”/100
Analyst data unavailable.

Latest News & Updates

News unavailable.